
Operational Survival Deficit of Neoadjuvant Chemotherapy in Early-Stage Breast Cancer: A Target Trial Emulation and Causal Machine Learning Study
<a href="https://news.google.com/rss/articles/CBMifEFVX3lxTE9vVW4xVTdfQzRpMEF5SXdaczlWMXhHWFA4YUducGR3c0pNVS1uUFY4M1pKOF9ZR056Mmx0aG9Zc0VZODdCZXZfdW4xYmVCQUJPa19yWk51YVZXSHJ3Y04wRzVTamZ1MVNOb2NFV0toMlJVbF9GdVoxN3U2Rk0?oc=5" target="_blank">Operational Survival Deficit of Neoadjuvant Chemotherapy in Early-Stage Breast Cancer: A Target Trial Emulation and Causal Machine Learning Study</a>&nbsp;&nbsp;<font color="#6f6f6f">medRxiv</font>

